Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
Medtronic
Moodys
Express Scripts
Harvard Business School
McKesson

Last Updated: December 11, 2019

DrugPatentWatch Database Preview

Litigation Details for Vanda Pharmaceuticals Inc. v. West-Ward Pharmaceuticals International Limited (D. Del. 2015)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Vanda Pharmaceuticals Inc. v. West-Ward Pharmaceuticals International Limited (D. Del. 2015)

Docket   Start Trial Date Filed 2015-10-13
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Gregory Moneta Sleet
Jury Demand None Referred To
Parties ROXANE LABORATORIES, INC.; VANDA PHARMACEUTICALS INC.; WEST-WARD PHARMACEUTICALS CORP.; WEST-WARD PHARMACEUTICALS INTERNATIONAL LIMITED
Patents 8,586,610; 9,138,432; RE39,198
Attorneys Bindu Ann George Palapura; Daniel J. Klein; David Ellis Moore; Derek James Fahnestock; Emily C. Melvin; Eric A. Stone; Ethan Haller mmTownsend; Ethan Haller Townsend; Jack B. Blumenfeld; Josephine Young; Karen Jacobs; Kenneth G. Schuler; Kira A. Davis; Lauren Sharkey; Michelle R. Ma; Nicholas Groombridge
Firms DLA Piper LLP; McDermott Will & Emery LLP; Morris, Nichols, Arsht & Tunnell
Link to Docket External link to docket
Small Molecule Drugs cited in Vanda Pharmaceuticals Inc. v. West-Ward Pharmaceuticals International Limited
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Vanda Pharmaceuticals Inc. v. West-Ward Pharmaceuticals International Limited (D. Del. 2015)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 1 infringement of a patent in the same family as the ’432 patent, namely U.S. Patent No. 8,586,610 (“the ’610….S. Patent No. RE39,198 (the ’198 patent). Because the ’198 patent expires before the ’432 patent will…infringement of claim 1 of Vanda’s U.S. Patent No. 9,138,432 (“the ’432 patent”), which relates to the field of…the ’432 patent, or any extensions thereof. Roxane will infringe claim 1 of the ’432 patent under 35 … to the methods of the ’432 patent prior to the expiration of that patent, or any extensions thereof. External link to document
2016-10-05 33 Plaintiffs (Nos. 1-14) directed to U.S. Patent No. 9,138,432 filed by Taro Pharmaceutical Industries,… 13 October 2015 1:15-cv-00919 830 Patent None District Court, D. Delaware External link to document
2016-10-10 35 Plaintiffs (Nos. 15-20) Directed to U.S. Patent No. 9,138,432 filed by Taro Pharmaceutical Industries,… 13 October 2015 1:15-cv-00919 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
McKinsey
Boehringer Ingelheim
Medtronic
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.